[1]
“Prolonged Survival on PARP Inhibitor Therapy In a Patient With Stage IV Non-small Cell Lung Cancer: A Case Report”, acmcr, vol. 3, no. 2, pp. 59–61, Mar. 2019, Accessed: Nov. 12, 2026. Available: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22121